Delayed neuroprotection against cerebral ischemia reperfusion injury: Putative role of BDNF and GSK-3β

Journal of Receptors and Signal Transduction

Volumn 36, Issue 4, 2016, Pages 402-410

  Taliyan, Rajeev ^a   Ramagiri, Sruthi ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

BDNF; brain; GSK 3; ischemia reperfusion; stroke

Indexed keywords

ACETYLCHOLINESTERASE; BRAIN DERIVED NEUROTROPHIC FACTOR; GLYCOGEN SYNTHASE KINASE 3; LITHIUM; TUMOR NECROSIS FACTOR ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; NEUROPROTECTIVE AGENT; TUMOR NECROSIS FACTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; BRAIN HOMOGENATE; BRAIN ISCHEMIA; BRAIN REGION; CELL SURVIVAL; COGNITIVE DEFECT; CONTROLLED STUDY; DOPPLER ULTRASONOGRAPHY; DRUG MEGADOSE; ENZYME ACTIVITY; HIPPOCAMPUS; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NEUROPROTECTION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE; PROTEIN DETERMINATION; RAT; REPERFUSION INJURY; SHORT TERM MEMORY; STATE DEPENDENT LEARNING; TREATMENT RESPONSE; UPREGULATION; WISTAR RAT; WORKING MEMORY; Y-MAZE TEST; ANIMAL; BIOSYNTHESIS; CEREBRAL ARTERY DISEASE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY;

ANIMALS; BRAIN ISCHEMIA; BRAIN-DERIVED NEUROTROPHIC FACTOR; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3 BETA; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; LITHIUM; MALE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RATS; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84964669817     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2015.1108338     Document Type: Article

References (45)

1. Durukan A, Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 2007; 87: 179-97
2. Hung LM, Huang JP, Liao JM, et al. Insulin renders diabetic rats resistant to acute ischemic stroke by arresting nitric oxide reaction with superoxide to form peroxynitrite. J Biomed Sci 2014; 21: 92
3. Nour M, Scalzo F, Liebeskind DS. Ischemia-reperfusion injury in stroke. Interv Neurol 2012; 1: 185-99
4. Hattori K, Lee H, Hurn PD, et al. Cognitive deficits after focal cerebral ischemia in mice. Stroke 2000; 31: 1939-44
5. Ye R, Yang Q, Kong X, et al. Sevoflurane preconditioning improves mitochondrial function and long-term neurologic sequelae after transient cerebral ischemia: role of mitochondrial permeability transition. Crit Care Med 2012; 40: 2685-93
6. Wei H, Yao X, Yang L, et al. Glycogen synthase kinase-3β is involved in electroacupuncture pretreatment via the cannabinoid CB1 receptor in ischemic stroke. Mol Neurobiol 2014; 49: 326-36
7. Wang, ZF, Fessler EB, Chuang DM. Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models. Acta Pharmacol Sin 2011; 32: 1433-45
8. Wang Z, Leng Y, Tsai LK, et al. Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J Cereb Blood Flow Metab 2011; 31: 52-7
9. Chuang DM, Wang Z, Chiu CT. GSK-3 as a target for lithium-induced neuroprotection against excitotoxicity in neuronal cultures and animal models of ischemic stroke. Front Mol Neurosci 2011; 4: 15
10. Leng Y, Liang MH, Ren M, et al. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition. J Neurosci 2008; 28: 2576-88
11. Croce N, Mathe AA, Gelfo F, et al. Effects of lithium and valproic acid on BDNF protein and gene expression in an in vitro human neuron-like model of degeneration. J Psychopharmacol 2014; 28: 964-72
12. Li H, Li Q, Du X, et al. Lithium-mediated long-term neuroprotection in neonatal rat hypoxia-ischemia is associated with antiinflammatory effects and enhanced proliferation and survival of neural stem/progenitor cells. J Cereb Blood Flow Metab 2011; 31: 2106-15
13. Zhu ZF, Wang QG, Han BJ, Willaim CP. Neuroprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in mice. Brain Res Bull 2010; 83: 272-7
14. Takahashi T, Steinberg GK, Zhao H. Lithium treatment reduces brain injury induced by focal ischemia with partial reperfusion and the protective mechanisms dispute the importance of akt activity. Aging Dis 2012; 3: 226
15. Xie C, Zhou K, Wang X, et al. Therapeutic benefits of delayed lithium administration in the neonatal rat after cerebral hypoxia-ischemia. PLoS One 2014; 9: e107192
16. Sharma S, Taliyan R. Neuroprotective role of Indirubin-3′-monoxime, a GSKβ inhibitor in high fat diet induced cognitive impairment in mice. Biochem Biophy Res Commun 2014; 452: 1009-15
17. Sharma S, Taliyan R. Synergistic effects of GSK-3β and HDAC inhibitors in intracerebroventricular streptozotocin-induced cognitive deficits in rats. Naunyn-Schmiedebergs Arch Pharmacol 2014; 388: 337-49
18. Pateliya BB, Singh N, Jaggi AS. Possible role of opioids and KATP channels in neuroprotective effect of postconditioning in mice. Biol Pharm Bull 2008; 31: 1755-60
19. Sharma S, Taliyan R, Ramagiri S. Histone deacetylase inhibitor, trichostatin A, improves learning and memory in high-fat diet-induced cognitive deficits in mice. J Mol Neurosci 2014; 56: 1-11
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75
21. Ellmann GL, Courtney KD, Andres V, Feather stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88-95
22. Wills E. Mechanisms of lipid peroxide formation in animal tissues. Biochem J 1966; 99: 667-76
23. Green LC, Wagner DA, Glogowski J, et al. Analysis of nitrate, nitrite, and [15 N] nitrate in biological fluids. Anal Biochem 1982; 126: 131-8
24. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-7
25. Pizzorusso T, Ratto GM, Putignano E, Maffei L. Brain-derived neurotrophic factor causes cAMP response element-binding protein phosphorylation in absence of calcium increases in slices and cultured neurons from rat visual cortex. J Neurosci 2000; 20: 2809-16
26. Platenik J, Fisar Z, Buchal R, et al. GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimers disease and depression. Prog Neuropsychopharmacol Biol Psychiatry 2014; 50: 83-93
27. Won J, Lee S, Park S, Hong Y. Protective effects of melatonin against ischemic neuronal damage in rats with transient focal cerebral ischemia. FASEB J 2015; 29: 186-92
28. Li WL, Cai HH, Wang B, et al. Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke. J Neurosci Res 2009; 87: 112-22
29. Xu J, Culman J, Blume A, et al. Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death. Stroke 2003; 34: 1287-92
30. Seo HG, Kim DY, Park HW, et al. Early motor balance and coordination training increased synaptophysin in subcortical regions of the ischemic rat brain. J Korean Med Sci 2010; 25: 1638-45
31. Ben Assayag E, Shenhar-Tsarfaty S, Ofek K, et al. Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality. Mol Med 2010; 16: 278
32. Eldar-Finkelman H, Martinez A. GSK-3 inhibitors: preclinical and clinical focus on CNS. Front Mol Neurosci 2011; 4: 32
33. King MK, Pardo M, Cheng Y, Downey K, Jope RS, Beurel E, et al. Glycogen synthase kinase-3 inhibitors: rescuers of cognitive impairments. Pharmacol Ther 2014; 141: 1-12
34. Ahmed T, Gilani AH. Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimers disease. Pharmacol Biochem Behav 2009; 91: 554-9
35. Saez-Valer J, Gonzalez-Garci A. Acetylcholinesterase activity and molecular isoform distribution are altered after focal cerebral ischemia. Mol Brain Res 2003; 117: 240-4
36. Sinha, K, Chaudhary G, Gupta YK. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci 2002; 71: 655-65
37. Lewen A, Matz P, Chan PH. Free radical pathways in CNS injury. J Neurotrauma 2000; 17: 871-90
38. Collino M, Thiemermann C, Mastrocola R, et al. Treatment with the glycogen synthase kinase-3β inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus. Shock 2008; 30: 299-307
39. McCoy MK, Tansey MG. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation 2008; 5: 45
40. Zaremba J, Losy J. Early TNF levels correlate with ischaemic stroke severity. Acta Neurol Scand 2001; 104: 288-95
41. Maixner DW, Weng HR. The role of glycogen synthase kinase 3 beta in neuroinflammation and pain. J Pharmaceu Pharmacol 2013; 1: 001
42. Woo NH, Lu B. Regulation of cortical interneurons by neurotrophins: from development to cognitive disorders. Neuroscientist 2006; 12: 43-56
43. Endo H, Nito C, Kamada H, et al. Activation of the Akt/GSK3β signaling pathway mediates survival of vulnerable hippocampal neurons after transient global cerebral ischemia in rats. J Cereb Blood Flow Metab 2006; 26: 1479-89
44. Zhao H, Shimohata T, Wang JQ, et al. Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neuroscience 2005; 25: 9794-806
45. Sasaki C, Hayashi T, Zhang WR, et al. Different expression of glycogen synthase kinase-3 β between young and old rat brains after transient middle cerebral artery occlusion. Neurol Res 2001; 23: 588-92